All lobbying filings
MADRIGAL PHARMACEUTICALS, INC.
MADRIGAL PHARMACEUTICALS, INC. filed a Q3 amendment for MADRIGAL PHARMACEUTICALS, INC. on December 4, 2025.
Lobbying for MADRIGAL PHARMACEUTICALS, INC. · Biopharmaceutical company
Filing · LD-2 quarterly report
Q3 amendment
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Dec 4, 2025
Expenses
$30,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Pennsylvania
Lobbying activity
1
Most Favored Nation drug pricing